Preparing for the FDA’s 2026 Human Factors Requirements
What the May 2026 FDA human factors guidance means for your medical device 510(k) submission The Food and Drug Administration issued an updated human factors guidance...
What to Expect During an FDA Quality System Inspection
As a medical device developer, when the time comes for an FDA inspection, it is entirely normal to feel a surge of pressure. Complex regulations and...
The R&D Force Multiplier: Shifting Cybersecurity from an Innovation “Tax” to a Strategic Market Asset
To a medical device product development leader, "cybersecurity" often sounds like a black hole for your R&D budget, a tax on innovation that doesn't add a...
Signs Your Medical Device Project Needs Regulatory Consulting Support
Transitioning from early development of your medical device to market readiness brings high stakes. You must meet strict FDA and EU MDR standards to ensure user...
Beyond the 510(k): Why Med-Tech Launches Stall Without Strategic Alignment
In the med-tech sector, a dangerous misconception persists: that obtaining an FDA clearance letter is the equivalent of a market success guarantee. As we navigate the...
The Budget-Shifter’s Memo: Moving Validation Costs from IT Infrastructure to Product R&D
Transition IT from a technical cost center to a strategic product enabler. This guide provides Hamilton County IT leaders with the exact ROI framework needed to...